corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published in 2012

There are 85 items in the Healthy Skepticism Library that were published in 2012.

Page 1 of 1 pages

HSL20446
Roehr B
Eli Lilly settles corrupt foreign practices complaint for $29.4m
BMJ 2012 Dec 27; 345:e8694
http://www.bmj.com/content/345/bmj.e8694

HSL20443
Sinha K
Govt to crack down on pharma-doctor nexus
Times of India 2012 Dec 26
http://articles.timesofindia.indiatimes.com/2012-12-26/india/36007441_1_drug-companies-drug-promotion-dcgi

HSL20442
Rodwin MA
Independent Clinical Trials to Test Drugs: The Neglected Reform
Saint Louis University Journal of Health Law & Policy 2012 Dec 24; 6:(12-58):113
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2193594

HSL20500
Ray K
Doc’s plaint stops vaccine ad on TV
The Deccan Herald 2012 Dec 14
http://www.deccanherald.com/content/298660/docs-plaint-stops-vaccine-ad.html

HSL20444
Boumil MM
Off-Label Marketing and the First Amendment
NEJM 2012 Dec 12; 368:103-105
http://www.nejm.org/doi/full/10.1056/NEJMp1214926

HSL20445
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L
Industry sponsorship and research outcome
The Cochrane Library 2012 Dec 12; (12):
http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000033.pub2/full

HSL19717
Segatto C
O real risco das novas pílulas
Época 2012 Dec 9
http://revistaepoca.globo.com/Saude-e-bem-estar/noticia/2011/12/o-real-risco-das-novas-pilulas.html

HSL20499
Hegde BM
Money is Mammon in pharmaceutical world
The Hindu 2012 Dec 9
http://www.thehindu.com/opinion/open-page/money-is-mammon-in-pharmaceutical-world/article4179010.ece

HSL20438
AstraZeneca’s cancer drug patent rejected
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295062/astrazenecas-cancer-drug-patent-rejected.html

HSL20439
Medicines for needy
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295055/medicines-needy.html

HSL20440
Kumar C
Govt pact with generic drug seller ‘illegal’
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295090/govt-pact-generic-drug-seller.html

HSL20441
Swan N
The High Costs of Pharmaceuticals in Australia
Health Report : Radio National 2012 Nov 260
http://www.abc.net.au/radionational/programs/healthreport/the-high-costs-of-pharmaceuticals-in-australia/4392196#transcript

HSL20432
Srinivasan S
Is the shift away from cost-plus drug pricing desirable? - NO
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-no/article4127203.ece?homepage=true

HSL20433
Shah DG
Is the shift away from cost-plus drug pricing desirable? - YES
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-yes/article4127199.ece?homepage=true

HSL20434
Ferner R
A short history of pharmaceutical marketing
BMJ 2012 Nov 20; 345:e7801
http://www.bmj.com/content/345/bmj.e7801

HSL20435
Karmali N
India's Pharma Kings Are The Country's Big Winners
Forbes 2012 Oct 25
http://www.forbes.com/sites/naazneenkarmali/2012/10/25/indias-pharma-kings-are-the-countrys-big-winners/

HSL20437
Devinney T
Integrity pays dividends: the case for minding your own business
The Conversation 2012 Oct 25
http://theconversation.edu.au/integrity-pays-dividends-the-case-for-minding-your-own-business-9301

HSL20436
Preston C, Valdez M, Bond K
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
PLoS Med 2012 Oct 23; 9:(10):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001327

HSL20422
Joelving F
Exclusive: Abbott suspends giving gifts to doctors in India
Reuters 2012 Oct 16
http://www.reuters.com/article/2012/10/16/us-abbott-india-doctors-idUSBRE89F1N820121016

HSL20421
Lewis H
Lies, damn lies and drug trials
New Statesman 2012 Oct 4
http://www.newstatesman.com/sci-tech/sci-tech/2012/10/lies-damn-lies-and-drug-trials

HSL20282
Supreme Court asks Centre not to alter pricing system for essential drugs
The Economic Times 2012 Oct 3
http://articles.economictimes.indiatimes.com/2012-10-03/news/34238803_1_essential-medicines-prices-control-steep-hike

HSL20284
Reynolds M
Australian Pharma companies bow to demanding doctors
6minutes.com 2012 Oct 2
http://www.6minutes.com.au/news/latest-news/transparency-will-expose-demanding-doctors

HSL20261
Thomas C
Medical journals: 'information-laundering for Big Pharma'?
The Ethical Nag 2012 Sep 26
http://ethicalnag.org/2012/09/26/medical-journals-information-laundering-big-pharma/

HSL20258
Luthra S
U. forgoes action against prof after study fraud
The Brown Daily Herald 2012 Sep 14
http://www.browndailyherald.com/u-forgoes-action-against-prof-after-study-fraud-1.2762909#.UFrj5I51A21

HSL20257
Bates A
How to Get More Sales from Your Sales Force Efforts
eyeforpharma 2012 Sep 4
http://social.eyeforpharma.com/column/how-get-more-sales-your-sales-force-efforts

HSL20402
Djulbegovic B, Hozo I, Beckstead J, Tsalatsanis A, Pauker SG
Dual processing model of medical decision-making
BMC Medical Informatics and Decision Making 2012 Sep 3; 12:(94):
http://www.biomedcentral.com/1472-6947/12/94/abstract

HSL20259
Lee M, Hirschler B
China's 'wild east' drug store
Reuters 2012 Aug 28
http://uk.reuters.com/article/2012/08/28/uk-china-pharmaceuticals-idUKBRE87R0OE20120828

HSL20260
Light DW, Lexchin JR
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012 Aug 11;
http://www.bmj.com/content/345/bmj.e4348

HSL20262
Harvey K
TGA failure gives Nurofen consumers a headache
The Conversation 2012 Aug 10
http://theconversation.edu.au/tga-failure-gives-nurofen-consumers-a-headache-8762

HSL20263
Bita N
Pharmaceutical companies spends $30m wining, dining doctors
The Australian 2012 Aug 10
http://www.theaustralian.com.au/news/health-science/pharmaceutical-companies-spends-30m-wining-dining-doctors/story-e6frg8y6-1226447086707

HSL20253
Unnikrishnan C
Doctors' freebies to be taxed
Times of India 2012 Aug 7
http://articles.timesofindia.indiatimes.com/2012-08-07/mumbai/33081949_1_freebies-pharma-firms-organization-of-pharmaceutical-producers

HSL20255
Kesselheim AS, Wang B, Studdert DM, Avorn J
Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
PLoS Med 2012 Aug 7; 9:(8):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001280

HSL20314
Jones MI
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2012 Aug 4; 323:1-7
http://www.bmj.com/content/323/7309/378.1

HSL20249
Barker A
EU to charge two drugmakers over generics
The Financial Times 2012 July 25
http://www.ft.com/intl/cms/s/0/d9ce8402-d671-11e1-bd9c-00144feabdc0.html#axzz21t7yPXo0

HSL20247
Fisher JA, Kalbaugh CA
United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
PLoS Med 2012 July 24; 9:(7):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001271

HSL20251
Saying 'no thanks' to the pharmaceutical industry's undue influence
Prescrire 2012 July 23;

HSL20254
Sharma H
Pharma firms funding foreign trips for doctors
IBN Live 2012 July 18
http://ibnlive.in.com/news/pharma-firms-funding-foreign-trips-for-doctors/271997-3-236.html

HSL20246
ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
HAI Europe 2012 July 16

HSL20248
‘Sponsored’ doctors under scanner
The New Indian Express 2012 July 11
http://newindianexpress.com/nation/article563870.ece

HSL20245
Glekin J
India's pro-poor policy may be getting healthier
Reuters Breakingviews 2012 July 5
http://in.reuters.com/article/2012/07/05/breakingviews-generic-drugs-idINDEE86404Y20120705?feedType=RSS&feedName=globalCoverage2

HSL20228
Glaxo to pay $3 bn for largest health fraud in US
The Washington Post 2012 July 3
http://www.washingtonpost.com/national/health-science/glaxosmithkline-to-pay-3b-in-largest-healthcare-fraud-settlement-in-us-history/2012/07/02/gJQArBKIJW_story_1.html

HSL20226
GlaxoSmithKline to pay $3bn in US drug fraud scandal
BBC News 2012 July 2
http://www.bbc.co.uk/news/world-us-canada-18673220

HSL20227
Karlin M
Big Pharma Drug Company Gets Fined 3 Billion Dollars for Marketing Abuse of Drugs, But No Criminal Charges
The Buzzflash Blog 2012 July 2
http://blog.buzzflash.com/node/13580

HSL20204
Ray K
Drug companies fleecing consumers: Study
The Deccan Herald 2012 Jun 15
http://www.deccanherald.com/content/257136/drug-companies-fleecing-consumers-study.html

HSL20225
Kaplan WA, Ritz LS, Vitello M, Wirtz VJ
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy 2012 Jun 13;
http://www.healthpolicyjrnl.com/article/S0168-8510(12)00132-7/abstract

HSL20205
Weissman R, So A
Generating Antibiotic Incentives Now: GAIN Or Just Greed
Citizen Vox 2012 Jun 12
http://www.citizenvox.org/2012/06/12/antibiotic-resistance-gain-ac/

HSL20161
Dabade G
When drug regulators play with people’s lives
The Deccan Herald 2012 May 22
http://www.deccanherald.com/content/251489/when-drug-regulators-play-peoples.html

HSL19768
Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1; 344:
http://www.bmj.com/content/344/bmj.e14

HSL19998
Big Pharma spends over €40 million per year lobbying in the EU, dwarfing public health NGOs
HAI Europe 2012 Mar 28
http://www.corporateeurope.org/pressreleases/2012/big-pharma-spends-over-40-million-year-lobbying-eu-dwarfing-public-health-ngos

HSL19999
Silverman E
Pharma Execs Admit: ‘Our Model Is Broken’
Pharmalot 2012 Mar 21
http://www.pharmalot.com/2012/03/pharma-execs-admit-our-model-is-broken/

HSL19977
Dunlevy S
Australian Big Pharma to derail gravy train Ken Harvey
The Australian 2012 Mar 19
http://www.theaustralian.com.au/news/health-science/big-pharma-to-derail-gravy-train/story-e6frg8y6-1226303285769

HSL19976
O'Brien M
'Unethical': NHMRC to reveal stance on homeopathy
Medical Observer 2012 Mar 14
http://www.medicalobserver.com.au/news/unethical-nhmrc-to-reveal-stance-on-homeopathy?utm_medium=email&utm_campaign=Medical+Observer+eNews+-+14032012&utm_content=Medical+Observer+eNews+-+14032012+CID_a5bbeb08c9b38c8cb25925305583a957&utm_source=Email+marketing+software&utm_term=Unethical+NHMRC+to+reveal+stance+on+homeopathy

HSL19961
Bajaj V, Pollack A
If Novartis wins, prices of drugs could sky-rocket
The Deccan Herald 2012 Mar 8
http://www.deccanherald.com/content/232801/if-novartis-wins-prices-drugs.html

HSL19941
Reid-Henry S
Novartis vs India: the showdown approaches
New Internationalist Blog 2012 Feb 28
http://www.newint.org/blog/2012/02/28/novartis-india-court-case-approaches/?utm_source=ni-enews-au-2012-03-05&utm_medium=email-html&utm_content=body&utm_campaign=new-internationalist-enews-oz-shop

HSL19996
Metherell M
Hunt for the truth behind diet pill
The Sydney Morning Herald 2012 Feb 18
http://www.smh.com.au/national/health/hunt-for-the-truth-behind-diet-pill-20120217-1tei9.html

HSL19997
Baloch F
Spurious drugs case: Pharma association’s acting chief blasts industry, regulator
The Express Tribune 2012 Feb 17
http://tribune.com.pk/story/337738/spurious-drugs-case-pharma-associations-acting-chief-blasts-industry-regulator/

HSL19849
Imprensa RP
Anvisa não pode mais vetar publicidade de medicamentos, diz Justiça
Portal Imprensa 2012 Feb 3
http://portalimprensa.uol.com.br/cdm/caderno+de+midia/47045/anvisa+nao+pode+mais+vetar+publicidade+de+medicamentos+diz+justica

HSL20000
Pickett FA
Misrepresentation of Scientific Studies Misleads Professional Caregivers
Dentition 2012 Feb; 1:(1):14-19
http://www.thedentition.com/ojs/index.php/dent/article/view/3/19

HSL19884
Brody H
Opinion: Celebrities Pushing Drugs?
The Scientist 2012 Jan 30
http://the-scientist.com/2012/01/30/opinion-celebrities-pushing-drugs/

HSL19821
Cohen D
Deborah Cohen: Roche responds
BMJ Group Blogs 2012 Jan 27
http://blogs.bmj.com/bmj/2012/01/27/deborah-cohen-roche-responds/

HSL19794
Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24; 9:(1):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001163

HSL19883
Key Opinion Leaders Who Lend Their Names to Ghostwritten Medical Articles Should Be Held Legally Liable, Article States
Baum, Hedlund, Aristei & Goldman 2012 Jan 24

HSL19796
Collins G
Call to axe starter packs
6minutes 2012 Jan 23
http://www.6minutes.com.au/news/latest-news/call-to-axe-starter-packs

HSL19783
Alexander J
Health ministry asks state drug controllers to closely monitor misleading ads on vitamins, creams
Pharmabiz 2012 Jan 18
http://pharmabiz.com/NewsDetails.aspx?aid=67061&sid=1

HSL19817
Laurance J
Implant danger extends to all medical devices
The Independent 2012 Jan 18
http://www.independent.co.uk/life-style/health-and-families/health-news/implant-danger-extends-to-all-medical-devices-6291116.html

HSL19816
Pear R
U.S. to Force Drug Firms to Report Money Paid to Doctors
The New York Times 2012 Jan 16
http://www.nytimes.com/2012/01/17/health/policy/us-to-tell-drug-makers-to-disclose-payments-to-doctors.html?_r=3&pagewanted=all

HSL19772
Dabade G
With 100% FDI in pharma, medicines may soon cost more
The Deccan Herald 2012 Jan 15
http://www.deccanherald.com/content/215612/with-100-fdi-pharma-medicines.html

HSL19763
Khor M
TWN Info Service on Intellectual Property Issues
Third World Network 2012 Jan 14
www.twnside.org.sg

HSL19882
Voreacos D, Cronin Fisk M, Feeley J
J&J Marketed Risperdal for Kids After FDA Warnings, Jurors Told
Bloomberg 2012 Jan 14
http://www.bloomberg.com/news/2012-01-13/j-j-marketed-risperdal-to-children-despite-u-s-fda-warnings-jurors-told.html

HSL19765
Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10; 344:
http://www.bmj.com/content/344/bmj.d8219

HSL19767
Christensen M, Knop FK
The unobtainable placebo: control of independent clinical research by industry?
The Lancet 2012 Jan 7; 379:(9810):30
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60024-5/fulltext

HSL19766
Shankar PR, Singh KK, Piryani RM
Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school
BMC Research Notes 2012 Jan 6; 5:(8):
http://www.biomedcentral.com/1756-0500/5/8/abstract

HSL19771
Fiddamen B
APA Use Restraints on Blogger
Seroxat Sufferers: Stand Up and Be Counted 2012 Jan 4
http://networkedblogs.com/skM9J?mid=56

HSL19769
Lehman R, Loder E
Missing clinical trial data
BMJ 2012 Jan 3; 344:
http://www.bmj.com/content/344/bmj.d8158

HSL19995
Cardenal Taján J
GSK fined after over vaccine trials; 14 babies reported dead
Buenos Aires Herald 2012 Jan 3
http://www.buenosairesherald.com/article/88922/gsk-lab-fined-over-vaccine-tests-that-killed-14--babies

HSL20203
Moynihan R
Kissing goodbye to key opinion leaders
Medical Journal of Australia 2012; 196:(11):671
https://www.mja.com.au/journal/2012/196/11/kissing-goodbye-key-opinion-leaders

HSL20250
Lexchin J, Vitry A
Should the C in CME Stand for Commercial?
Southern Med Review 2012; 5:(1):3-5
http://www.southernmedreview.org/index.php/smr/article/view/1028/31

HSL20252
Grills NJ
The ethics of industry sponsorship of charities
MJA 2012; 197:(3):139
https://www.mja.com.au/journal/2012/197/3/ethics-industry-sponsorship-charities

HSL20266
Wolfe SM
The seven-year rule for safer prescribing
Aust Prescr 2012; 35:(5):138-9
http://www.australianprescriber.com/magazine/35/5/138/9

HSL20283
Puliyel J
Compensation for Victims of Clinical Trials: A Discussion on How Current Indian Rules and Guidelines are Hurting India
Journal of Clinical and Diagnositic Research 2012;
http://www.jcdr.net/articles/pdf/2389/jcdr-6-1367.pdf

HSL19994
McNamara S
Antidepressant research divides experts
MJA Insight 2012 03 12; (9):
http://www.mjainsight.com.au/view?post=antidepressant-research-divides-experts&post_id=8416&cat=issue-9-12-march-2012

HSL20243
Phillips & Cohen
Whistleblower ('qui tam') lawsuit against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012
http://www.glaxowhistleblowers.com/lawsuit/

HSL20244
Phillips & Cohen
Glaxo’s settlement agreement and the government’s charges against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012
http://www.glaxowhistleblowers.com/settlement-agreement/

HSL20256
Harvey K
Pfizer Includes Foreign Corrupt Practices Act Violations in Its Arsenal of Illegal Activities
Worst Pills, Best Pills 2012 Sep
https://www.worstpills.org/login.cfm?redirected=1&page=/member/newsletter.cfm&qString=n%5Fid%3D812

HSL20296
Boldrin M, Levine DK
The Case Against Patents
Federal Reserve Bank of St Louis 2012
http://research.stlouisfed.org/wp/more/2012-035

Page 1 of 1 pages

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







There is no sin in being wrong. The sin is in our unwillingness to examine our own beliefs, and in believing that our authorities cannot be wrong. Far from creating cynics, such a story is likely to foster a healthy and creative skepticism, which is something quite different from cynicism.”
- Neil Postman in The End of Education